T315I - a gatekeeper point mutation and its impact on the prognosis of chronic myeloid leukemia
{{output}}
Objectives: BCR-ABL kinase domain mutations are an important cause of resistance to tyrosine kinase inhibitors (TKIs) in chronic myeloid leukaemia (CML) of which T315I is the most treatment-resilient. This study aimed to observe ... ...
